In future studies, whether the expression of PD-1/PD-L1 in the immune cells of MS patients is lower than that of patients with non-autoimmune diseases can be detected using flow cytometry or polymerase chain reaction. This evidence concerns the gene PDCD1 and myeloid sarcoma.